Metformin attenuates inflammasome activation and pro-inflammatory cytokine TNF-α and IL-6 levels while increasing anti-inflammatory IL-10 levels, suggesting that autophagy may control the SN inflammatory response in an in vivo model of PD. The gene discussed is IL10; the disease is Parkinson disease.